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The insulin/Akt pathway controls a specific 
cell division program that leads to generation 
of binucleated tetraploid liver cells in rodents
Séverine Celton-Morizur,1,2 Grégory Merlen,1,2 Dominique Couton,1,2  
Germain Margall-Ducos,1,2 and Chantal Desdouets1,2
1Institut Cochin, Université Paris Descartes, CNRS UMR 8104, Paris, France. 2INSERM U567, Paris, France.
The	formation	of	polyploid	cells	is	part	of	the	developmental	program	of	several	tissues.	During	postnatal	
development,	binucleated	tetraploid	cells	arise	in	the	liver,	caused	by	failure	in	cytokinesis.	In	this	report,	
we	have	shown	that	the	initiation	of	cytokinesis	failure	events	and	the	subsequent	appearance	of	binucleated	
tetraploid	cells	are	strictly	controlled	by	the	suckling-to-weaning	transition	in	rodents.	We	found	that	daily	
light/dark	rhythms	and	carbohydrate	intake	did	not	affect	liver	tetraploidy.	In	contrast,	impairment	of	insulin	
signaling	drastically	reduced	the	formation	of	binucleated	tetraploid	cells,	whereas	repeated	insulin	injec-
tions	promoted	the	generation	of	these	liver	cells.	Furthermore,	inhibition	of	Akt	activity	decreased	the	num-
ber	of	cytokinesis	failure	events,	possibly	through	the	mammalian	target	of	rapamycin	signaling	complex	2	
(mTORC2),	which	indicates	that	the	PI3K/Akt	pathway	lies	downstream	of	the	insulin	signal	to	regulate	the	
tetraploidization	process.	To	our	knowledge,	these	results	are	the	first	demonstration	in	a	physiological	con-
text	that	insulin	signaling	through	Akt	controls	a	specific	cell	division	program	and	leads	to	the	physiologic	
generation	of	binucleated	tetraploid	liver	cells.
Introduction
Polyploidy, the state of having greater than a diploid DNA content 
(tetraploid, octoploid, etc.), is a widespread physiological phenom-
enon observed particularly in plants, fish, and amphibians (1). 
Although it is less common in mammals, some tissues — includ-
ing heart muscle cells, platelet progenitor megakaryocytes, and 
liver parenchyma — develop a certain degree of polyploidy during 
their normal life cycle. The appearance of polyploid cells is often 
associated with late fetal development and coincides with termi-
nal differentiation (2, 3). Polyploid cells can be also formed in 
response to stress and injury, as has been described previously for 
uterine smooth muscle during pregnancy (4), heart muscle cells 
and VSMCs during hypertension (5, 6), and thyroid cells in hyper-
thyroidism (7, 8). Moreover, in many human carcinomas, cells with 
polyploid DNA content arise as an early step in tumorigenesis and 
precede the formation of aneuploid cells (8, 9).
Polyploidy is a characteristic feature of mammalian hepatocytes 
(10). During postnatal growth, the liver undergoes substantial 
changes, including gradual polyploidization. This process gen-
erates the successive appearance of tetraploid and octoploid 
hepatocytes with 1 (mononucleated; e.g., 4n, 8n) or 2 nuclei 
(binucleated; e.g., 2×2n, 2×4n). In adults, 70% of all hepatocytes in 
rodents and 40% in humans are tetraploid (11, 12). Interestingly, in 
the adult liver, the generation of polyploid cells can be reinduced 
following a variety of cellular stressors. Liver regrowth after partial 
hepatectomy or following oxidative damage and metabolic over-
load (copper/iron) is associated with a pronounced increase in the 
proportion of cells that are polyploid (13–16).
One fascinating question is how diploid organisms give rise to 
polyploid cells. In some cell types, such as skeletal muscle cells and 
osteoclasts, cell fusion is a normal developmentally programmed 
step and leads to the production of terminally differentiated 
polyploid cells (17, 18). Polyploid cells can also be generated by 
endoreplication, as has been observed previously in megakaryo-
cytes and vascular smooth muscle cells (19, 20); during this spe-
cialized cell cycle, cells skip mitosis and proceed to several rounds 
of DNA replication. Finally, cytokinesis might fail because of a 
disturbance of cleavage furrow formation. Such cytokinesis fail-
ure has been clearly identified during pathological division (9). 
Using live-cell microscopy, we previously demonstrated that, sur-
prisingly, hepatocytes become polyploid by physiological failure 
of cytokinesis (21). Diploid hepatocytes undergo mitosis, but do 
not form a contractile ring. Indeed, cleavage-plane specification 
is never established, because of deficiencies of actin cytoskeleton 
reorganization. Consequently, microtubules fail both to contact 
the cortex and to deliver their molecular signal, preventing local-
ization and activation of RhoA. Therefore, cytokinesis aborts, and 
a binucleated tetraploid liver cell is generated (22). This specific 
cell cycle program takes place at weaning. During this period, dip-
loid hepatocytes engage either into a normal cell cycle, giving rise 
to 2 diploid hepatocytes, or do not complete cytokinesis, and gen-
erate a single tetraploid hepatocyte with 2 nuclei (21). The genera-
tion of such binucleated tetraploid cells is the crucial step for the 
establishment of polyploidization during postnatal liver growth. 
Indeed, if this hepatocyte divides again, mononucleated tetraploid 
progenies will be generated.
To our knowledge, the cell signaling mechanism that controls 
the cytokinesis failure program and leads to the generation of a 
binucleated tetraploid liver cell has not previously been elucidated. 
In this report, we demonstrate that the PI3K/Akt pathway, down-
stream from insulin signaling, controlled this specific division pro-
gram and thus the generation of binucleated tetraploid liver cells.
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Results
Generation of binucleated tetraploid hepatocytes is controlled by the suck-
ling-to-weaning transition. We first investigated the involvement of 
animal weaning in the control of cytokinesis failure events by ana-
lyzing mitosis events on tissue liver sections (Figure 1A). When 
hepatocytes completed cytokinesis, a particular microtubule struc-
ture, called midbody, was formed, and the cell adopted a shape 
characteristic of cleavage furrow ingression. In contrast, when 
hepatocytes did not complete cytokinesis, microtubule networks 
were clearly disorganized, and membrane ingression was absent. 
In rats weaned at age 19 days and fed a high-carbohydrate diet for 
4 days (Figure 1B), we observed that a high proportion of divid-
ing hepatocytes did not complete cytokinesis (43.0% ± 0.8%; Figure 
1C and ref. 22). In rats suckling until 19 days, most hepatocytes 
completed cytokinesis, whereas in their littermates weaned at age 
15 days and fed a high-carbohydrate diet until 19 days, already 
36.9% ± 5.2% of hepatocytes failed to complete cytokinesis (Figure 
1C). Thus, the widespread failure of cytokinesis in hepatocytes, 
and the consequent generation of binucleated tetraploid cells, was 
controlled by the suckling-to-weaning transition.
Daily rhythms and carbohydrate supply do not affect the tetraploidy 
process. The suckling-to-weaning transition is associated with 
modifications of various physiological processes, both nutritional 
and hormonal (23). Suckling animals are on a low-carbohydrate, 
high-fat diet (maternal milk) and, after weaning, are shifted to a 
high-carbohydrate, low-fat diet. In parallel, large modifications 
in the concentration of circulating hormones, such as glucagon 
and insulin, are observed; respectively, they are high and low dur-
ing suckling and the reverse after weaning. Furthermore, daily 
rhythms progressively emerge during this physiological transition. 
In the liver, DNA synthesis and mitotic index are correlated with 
the diurnal period (24, 25). We therefore tested whether one or 
several of these parameters control liver tetraploidization.
We first assessed whether modulation of daily rhythms affected 
the generation of binucleated tetraploid hepatocytes by modify-
ing the daily light/dark cycle for 1 week after weaning (Figure 2A). 
At this stage of liver development, the tetraploidization process 
is already strongly engaged (21). We used simultaneous immuno-
labeling of nuclear and plasma membranes in tissue sections to 
distinguish between diploid and tetraploid fractions (Figure 2B). 
Perturbation of daily rhythms did not interfere with the genera-
tion of binucleated tetraploid hepatocytes (Figure 2C).
We next tested whether nutritional supply, particularly an 
increase in the carbohydrate content of the diet, affected the gener-
ation of binucleated tetraploid hepatocytes. Rats from the same lit-
ter were fed for 6 days with either a high-carbohydrate, low-fat diet 
or a low-carbohydrate, high-fat diet (Figure 3A). Because long-term 
high-fat dieting may induce hyperinsulinemia and hyperglycemia 
(26), we tested whether blood glucose and insulin levels were modi-
fied in our conditions of short-term high-fat diet feeding; no signif-
icant increase was observed (Figure 3B). In parallel, we analyzed the 
expression levels of key factors controlling glycolytic and lipogenic 
pathways, including SREBP-1c, glucokinase (GK), liver–pyruvate 
kinase (L-PK), and fatty acid synthase (FAS) (27). Under short-term 
high-fat diet feeding, SREBP-1c and GK expressions were unaf-
fected (Figure 3, C and D), which indicates that the insulin signal-
ing pathway was functional. Conversely, a significant decrease of 
FAS (insulin and glucose signaling) and L-PK expression (glucose 
signaling only) was observed in the high-fat diet group (Figure 3, C 
and D), indicating that glucose signaling was impaired. In both diet 
conditions, we quantified the percentage of diploid and tetraploid 
hepatocyte populations (see Figure 2B), and found that the differ-
ent diets did not perturb the generation of binucleated tetraploid 
hepatocytes (Figure 3E). Together, these data indicate that glucose 
signaling is not essential for tetraploidization in the liver.
Insulin concentration regulates generation of binucleated tetraploid 
hepatocytes. To reduce the level of circulating insulin, rats were 
treated before weaning with streptozotocin (STZ), which selectively 
destroys pancreatic β cells (Figure 4A). STZ-treated rats showed 
Figure 1
Cytokinesis failure is induced by the suckling-to-weaning transition. 
(A) Immunostaining of liver sections with β-catenin (plasma membrane 
labeling) and β-tubulin (microtubule labeling). Images of telophase 
were visualized as condensed chromatin staining (Hoechst 33342). 
Immunostaining allowed telophases that completed cytokinesis to be 
distinguished from those that did not. Scale bar: 10 μm. (B) Left: Rats 
from the same litter were either weaned at age 15 days and fed a 
high-carbohydrate diet or left with their mother with no access to solid 
food. All rats were sacrificed at 19 days of age. Right: Rats from a 
single litter were weaned at 19 days of age, fed a high-carbohydrate 
diet, and sacrificed at day 23. (C) Cytokinesis in 19-day suckling and 
in 19- and 23-day weaned rats as in B. Percentages of normal cyto-
kinesis and cytokinesis failure were calculated by analysis of β-catenin, 
β-tubulin, and Hoechst immunostaining on tissue sections. For each 
animal, 50 telophases were analyzed. Results are means ± SEM 
(n = 6 per group). *P < 0.05.
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substantially reduced levels of circulating insulin and hyperglyce-
mia 5 days after the end of treatment (Figure 4B). We analyzed the 
effect of this treatment on the expression of genes regulated by 
insulin and glucose. STZ treatment downregulated both insulin 
and glucose pathways, as expected. The expression of SREBP-1c, 
GK, FAS, and L-PK decreased, as assessed by quantitative real-
time PCR and Western blotting (Figure 4, C and D). Moreover, the 
amount of phospho-Akt (Ser473 residue) was lower in STZ-treated 
rats than in controls (Figure 4D), again reflecting the impair-
ment of the insulin pathway. Importantly, we demonstrated that 
in this condition, the binucleated tetraploid hepatocyte content 
(4.1% ± 3.7%) was much lower in STZ-treated rats than in control 
animals (19.9% ± 6.6%; Figure 4E). We previously illustrated that 
by isolating primary hepatocytes during postnatal liver develop-
Figure 2
Influence of circadian clock on the tetraploidy process. (A) Rats were weaned at 19 days of age and fed a high-carbohydrate diet; individuals from 
the same litter were assigned to light/dark cycles of 12:12, 18:6, or 21:3 hours. All rats received a high-carbohydrate diet and were sacrificed at 
25 days of age. (B) Image of tissue section after double staining with β-catenin and Hoechst, illustrating the difference between diploid and tetra-
ploid hepatocytes. Scale bar: 10 μm. (C) Percent binucleated tetraploid cells was calculated by analysis of β-catenin/Hoechst immunostaining. 
Histogram shows mean ± SEM of 3 independent experiments. A minimum of 2,500 hepatocytes in 8–12 separate, randomly selected fields was 
analyzed (n = 5 per group).
Figure 3
Influence of carbohydrate intake on the tetraploidy process. (A) Rats from the same litter were weaned at 19 days of age; half of the rats were 
assigned to a high-carbohydrate (HC) diet and the other half to a high-fat (HF) diet. Before sacrifice on day 25, rats were fasted for 24 hours and 
then refed their respective diets for 18 hours. (B) Fed blood glucose and serum insulin concentrations were measured in all animals before sacri-
fice. Results are mean ± SEM for at least 8 animals per group. (C) Total RNA was extracted from rat livers (n = 5 [high carbohydrate]; 9 [high fat]) 
and analyzed by quantitative real-time PCR to estimate the abundance of SREBP-1c, L-PK, and FAS mRNAs. Values are normalized to that for 
cyclophilin mRNA, **P < 0.01. (D) Protein extracts were prepared from liver tissue from high-carbohydrate or high-fat diet–fed rats and subjected to 
immunoblotting with antibodies against SREBP-1c (precursor form; pSREBP-1c), GK, and FAS proteins. γ-Tubulin was used as a loading control. 
A representative Western blot is shown. (E) The percentage of binucleated tetraploid cells was calculated as described in Figure 2C. Histogram 
shows mean ± SEM of 3 independent experiments (n = 14 per group).
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ment, we were able to follow ex vivo the tetraploidization process 
(22). To confirm our in vivo findings, we used this technique to 
test whether hepatocytes from STZ-treated animals were able to 
progress through the cell cycle and complete cytokinesis to gener-
ate diploid progeny (Figure 4A). In our culture conditions, 80% 
of hepatocytes from control and STZ-treated animals progressed 
through S phase 48 hours after plating, with the maximal mitotic 
index occurring 60 hours after plating (data not shown). Cyto-
kinesis was analyzed by triple labeling of nucleus, microtubules, 
and membranes (Figure 4F). Cytokinesis failure was observed in 
1.8% ± 0.3% of STZ-treated hepatocyte events, a value much lower 
than the 20.5% ± 2.7% for control hepatocytes (Figure 4G). These 
findings demonstrate that decreasing the insulin level resulted 
in almost all hepatocytes engaging in a normal cell cycle and led 
to generation of diploid progeny. To reinforce these findings, we 
analyzed the alteration of tetraploidy process in the ob/ob mouse 
model, in which, like the STZ model, insulin signaling is impaired 
during postnatal liver growth. In the 
ob/ob model, insulin resistance first 
starts at the postweaning period and 
is well established at adult age (28). At 
5 weeks after birth, Akt signaling was 
already impaired in this model (Fig-
ure 5A). Furthermore, the percentage 
of binucleated tetraploid hepatocytes 
was significantly lower than that in 
control mice (25.4% ± 1.8%; Figure 5, 
B and C). Together, these results indi-
cate that impairment of insulin sig-
naling inhibits generation of binucle-
ated tetraploid progenies.
Next, we tested whether an increase 
in the insulin concentration could by 
itself induce generation of binucle-
ated tetraploid cells. We determined 
the proliferative capacity of the 
hepatocytes and their insulin respon-
siveness during postnatal liver growth 
by studying the Ki67 labeling index. 
At days 15–20, just before weaning, 
proliferation decreased substantially, 
and the subsequent suckling-to-
weaning transition beginning at day 
20 was associated with an increase 
in the proliferation index (Figure 
6A). The expression of IR increased 
specifically after weaning, correlated 
with the activation of insulin-regu-
lated genes GK and phospho-Akt 
(Figure 6B). We therefore tested 
whether an increase in insulin levels 
at the suckling-to-weaning transition 
stimulates generation of binucleated 
tetraploid liver cells. Rats from the 
same litter were injected with insulin 
or its vehicle around weaning (Figure 
6C). In insulin-treated rats, the level 
of phospho-Akt was higher than that 
in control rats (Figure 6D). Remark-
ably, the proportion of hepatocytes 
from insulin-treated rats that were tetraploid was 32.2% ± 14.6% 
higher than that from control animals (Figure 6E). Together, these 
observations demonstrate that insulin regulated generation of 
liver binucleated tetraploid cells.
AKT downstream from insulin signaling regulates generation of binu-
cleated tetraploid hepatocytes. We investigated how insulin controls 
the cytokinesis program. In our system, cytokinesis failure occurs 
as a result of the absence of cytoskeleton reorganization, which 
leads to the inactivation of RhoA signaling (22). The PI3K/Akt 
pathway appears to be one of the principal downstream path-
ways mediating the cellular effects of insulin. In particular, signal 
transduction via the mammalian target of rapamycin (mTOR) has 
been the subject of intense investigation (29, 30). Briefly, mTOR 
signaling complex 1 (mTORC1) is a key regulator of growth factor 
and nutrient signaling. S6 kinase is the best-characterized down-
stream effector of mTORC1. mTORC2 has a role in regulating 
the actin cytoskeleton and activating Akt through Ser473 phos-
Figure 4
Decreased insulin level abolishes generation of binucleated tetraploid hepatocytes. (A) Rats from the 
same litter were injected with STZ or vehicle, weaned at 20 days of age, and fed a high-carbohydrate 
diet. After a postprandial phase, rats were sacrificed at 24 days for in vivo analysis (D) or for isolating 
primary hepatocytes (E and F). (B) Fed blood glucose and serum insulin concentrations were mea-
sured in all animals at 24 days. Results are mean ± SEM for at least 6 animals per group. Con, control. 
(C) Total RNA was extracted from control (Con) and STZ-treated rat livers (n = 3), and SREBP-1c, 
L-PK, and FAS mRNA levels were analyzed by quantitative real-time PCR. Values are normalized to 
cyclophilin mRNA. (D) Protein extracts were prepared from liver tissue from control or STZ-treated rats 
and subjected to immunoblotting with antibodies against the precursor form of SREBP-1c, GK, FAS, 
and phospho-Akt (Ser473) (P-Akt). γ-Tubulin was used as a loading control. A representative Western 
blot is shown. (E) Percentage of tetraploid cells. Histogram shows mean ± SEM of 3 independent 
experiments (n = 6 [control]; 15 [STZ]). (F) Primary hepatocytes isolated from control and STZ-treated 
rats were immunostained for β-catenin, β-tubulin, and Hoechst for analysis of normal cytokinesis and 
cytokinesis failure. Scale bars: 10 μm. (G) Percentage of cytokinesis failure events for rats in F. For 
each condition, 100 telophases were analyzed. Results are mean ± SEM (n = 2 per group). *P < 0.05, 
**P < 0.01, #P < 0.005 versus control.
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phorylation. We therefore tested whether modulating the PI3K/
Akt pathway affects the cytokinesis program. Primary hepatocytes 
were isolated from fed rats and treated with specific inhibitors of 
the PI3K/Akt pathway. Because of the central role played by this 
pathway at the G1/S transition, pharmacological inhibitors were 
added to the culture medium after cells had finished S phase (48 
hours after plating) and entered mitosis (60 hours after plating). 
First we studied the effects of LY294002, a selective PI3K inhibi-
tor, on the cultured hepatocytes. As expected, LY294002 treatment 
substantially reduced Akt and S6 ribosomal phosphorylation 
(Figure 7A). Remarkably, this treatment significantly decreased 
cytokinesis failure events (46.4% ± 17.1% fewer than in control-
treated animals; Figure 7B). We tested whether the alteration of 
the MAPK pathway, another major pathway conducting the cel-
lular effects of insulin, affected the cytokinesis program. We found 
that hepatocytes treated with the MEK inhibitor U0126 presented 
the same cytokinesis failure rate as untreated control hepatocytes 
(Figure 7, A and B). To further assess the role of the PI3K path-
way, we tested the effects of a specific inhibitor of Akt, iAkt VIII, 
which prevents Akt phosphorylation (Figure 7A). This direct inhi-
bition of Akt decreased the frequency of cytokinesis failure events 
by 32.4% ± 8.2% (Figure 7B). We also examined the cytoskeleton 
organization in treated cells: iAkt-treated cells that completed 
Figure 5
Liver tetraploidy process in ob/ob mice. (A) Immunoblotting with 
antibody against phospho-Akt (Ser473). γ-Tubulin was used as a 
loading control. A representative Western blot is shown (n = 4 per 
group). (B) Tissue section after double staining with β-catenin and 
Hoechst, illustrating the difference between diploid and tetraploid 
hepatocytes in 5-week-old WT and ob/ob mice. Scale bar: 10 μm. 
(C) Percentage of tetraploid cells in WT and ob/ob mice (n = 4 per 
group). *P < 0.05 versus WT.
Figure 6
The increase of the circulating insulin concentration around weaning induces generation of binucleated tetraploid liver cells. (A) Proliferative 
status of hepatocytes during postnatal development (gray, suckling period; pink, feeding period). Tissue sections were immunostained for 
Ki67. Results are mean ± SEM (n = 4 per time point). (B) Protein extracts were prepared from liver tissues on days 8–25 and subjected to 
immunoblotting with antibodies against IR, GK, and phospho-Akt (Ser473). γ-Tubulin was used as a loading control. Shown are a representa-
tive Western blot (n = 5 per group) and a graph of IR expression. (C) Rats from the same litter were injected with insulin or vehicle during the 
suckling-to-weaning transition. All rats were weaned at age 20 days, fed a high-carbohydrate diet, and sacrificed at 24 days. (D) Immunoblot-
ting with antibody against phospho-Akt (Ser473). γ-Tubulin was used as a loading control. A representative Western blot is shown (n = 5 per 
group). (E) Percentage of binucleated tetraploid cells, calculated as described in Figure 2C. Histogram shows mean ± SEM of 3 independent 
experiments (n = 6). **P < 0.01 versus vehicle control.
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cytokinesis reorganized the actin cytoskeleton and recruited RhoA 
to the equatorial cortex, in contrast to cells that did not complete 
cytokinesis (Figure 7C). To study the potential role of mTORC1 
and mTORC2, primary hepatocytes were treated with rapamy-
cin. As previously described in other cell types (31, 32), rapamycin 
specifically inhibited mTORC1 (phosphorylation of Ser240/244 
on S6 ribosomal protein) and not mTORC2 (phosphorylation of 
Ser473 on Akt; Figure 7D). We observed that rapamycin-treated 
cells presented the same cytokinesis failure rate as did untreated 
cells (Figure 7E). This result indicates that mTORC1 does not 
regulate generation of liver tetraploid cells. The present findings 
reveal that Akt, directly or indirectly through mTORC2, controlled 
the cytokinesis program and consequent generation of binucle-
ated tetraploid hepatocytes.
Discussion
Although most eukaryotic organisms are diploid, many cells have 
more than 2 chromosome sets. Some mammalian tissues and 
organs have significant numbers of tetraploid cells that arise dur-
ing either physiological or pathological growth. Does the polyploid 
state represent an advantage or a disadvantage for a cell? Interest-
ingly, phenotypic analysis indicates that increasing ploidy can ori-
ent cell physiology toward particular functions (33, 34). However, 
generation of polyploid cells can also trigger cell transformation 
and tumor formation (35). It has been clearly shown that hepatic 
proliferation both during development and in challenging circum-
stances, such as after partial hepatectomy or oxidative damage, is 
associated with ploidization (10). In this context, defining which 
signals trigger generation of polyploid cells may bring new insight 
into the physiological properties of these cells and consequently 
their functions. Here we show, for the first time to our knowledge, 
that insulin signaling controlled a specific division program that 
led to generation of binucleated tetraploid liver cells.
We first revealed that cytokinesis failure was controlled by 
suckling-to-weaning changes. Indeed, nutritional and hormonal 
changes appearing during this period greatly modify glucose and 
fatty acid metabolism (23). In parallel to these metabolic changes, 
we observed a new wave of proliferation in the liver that was associ-
ated with the establishment of adaptive cell cycles. Neither the car-
bohydrate content of the diet nor changes in daily rhythms during 
this transition appeared to be involved in this specific division pro-
gram. We demonstrated that insulin, independent of its action on 
glucose signaling, controlled the extent of cytokinesis failure and 
thus generation of binucleated tetraploid liver cells. This observa-
tion is supported by our finding that when insulin signaling was 
impaired at weaning, diploid hepatocytes engaged in a cell cycle 
leading to the generation of diploid progeny. Consistent with this 
finding, elevation of the circulating insulin concentration was suf-
ficient to induce the appearance of binucleated tetraploid progeny. 
We thus describe an unforeseen mechanism of action for insulin 
in the control of cell cycle completion. In the past, extensive stud-
ies with yeast, metazoans, and mammals have clearly established 
that the insulin signaling pathway regulates cell proliferation and 
growth to create organs of reproducible size and shape (36). Cel-
lular growth and proliferation are coordinated by specific check-
points in G1 or G2 phases. Interestingly, a recent study in Drosophila 
reports that insulin signaling can influence cell number through 
the balance between its ability to accelerate progression through 
G1/S and delays at the G2/M transition (37). Here we demonstrate, 
for the first time to our knowledge, that insulin also controlled 
late mitosis progression in mammals by regulating cytokinesis.
The process of cytokinesis can be divided into 4 stages: specifica-
tion of the cleavage plane, formation and then ingression of the 
contractile ring, and finally cell abscission (38). Each stage is depen-
dent on the proper execution of the prior stage; thus, interference 
with any stage may result in cytokinesis failure (39). In the liver, 
cytokinesis failure occurs as a result of the absence of actin cytoskel-
eton organization at the cleavage plane. Consequently, active RhoA 
does not concentrate at the putative site of furrow formation, lead-
ing to an absence of activation of its downstream signals (22). How 
does insulin control this specific cell cycle program? The PI3K/Akt 
pathway, a mediator of insulin signaling, controls many cellular 
Figure 7
Akt regulates liver tetraploidy. (A and D) Drugs LY294002 
(LY), iAkt VIII (iAkt), U0126, and rapamycin (Rapa) or 
DMSO control were added to primary hepatocyte cultures 
of 24-day-old rats 60 hours after plating. Protein extracts 
were prepared and subjected to Western blotting with 
antibodies against phospho-Akt (Ser473), phospho–S6 
ribosomal protein (Ser240/244; P-S6R), and phospho-
Erk1/2 (P-Erk1/2). γ-Tubulin was used as a loading con-
trol. Representative Western blots are shown. (B and E) 
Percentage of cytokinesis failure events in control and 
treated hepatocytes, calculated by analysis of β-catenin, 
β-tubulin, and Hoechst staining (see Figure 4F). For 
each condition, 100 telophases were analyzed. Results 
are representative of 4 independent cultures. (C) Primary 
hepatocytes rats were immunostained for F-actin, RhoA, 
and Hoechst for analysis of normal cytokinesis and cyto-
kinesis failure. Scale bars: 5 μm. *P < 0.05, **P < 0.01 
versus control.
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processes, including cytoskeleton organization. In yeast, TORC2 
regulates actin cytoskeleton polarization (31); likewise, mTORC2 
was previously shown to regulate actin cytoskeleton reorganiza-
tion (32, 40). In mammalian cells, Akt regulates the activity of the 
ankyrin-repeat domain–containing protein Kank, a central pro-
tein involved in RhoA-dependent formation of actin stress fibers 
and cell migration (41). Recently, it was shown that Akt directly 
downregulates glycogen synthase kinase–3 (GSK-3) and thus acts 
on microtubule cytoskeleton during early mitosis (42). Our find-
ings support the concept, which we believe to be novel, that the 
PI3K/Akt pathway is a key actor in the cytokinesis process, which, 
like cell polarization and migration, requires specific regulation of 
cytoskeleton networks. Indeed, inhibition of PI3K during mitosis 
progression prevented cytokinesis failure and consequently com-
mitted the cells to divide into diploid progeny. We provide evidence 
that mTORC1 was not involved in this process. In contrast, direct 
inhibition of Akt led to the same phenotype as PI3K inhibition and 
oriented the cell to perform a complete cytokinesis, characterized 
by actin cytoskeleton reorganization and active RhoA localization 
to the cleavage plane. Further investigations will be necessary to 
define whether Akt contributes directly, or in association with 
mTORC2, to generation of binucleated tetraploid liver cells.
Future studies should investigate why this specific division 
program emerges under an insulin signal during the suckling-to-
weaning transition. It is possible that cells escape cytokinesis, a 
process consuming substantial energy, to respond to this meta-
bolic transition. Alternatively, the tetraploidization process may 
be required for the cell to engage in particular metabolic functions 
required at this step for liver development. Interestingly, mega-
karyocyte polyploidization regulates the gene expression involved 
in platelet biogenesis (34). Consequently, it would be particularly 
interesting to compare the metabolic functions of diploid and 
polyploid liver cells.
In conclusion, our results revealed that modulation of the 
insulin concentration, and consequently Akt activity, oriented 
hepatocytes into a specific cell cycle program, leading to genera-
tion of binucleated tetraploid cells. Because the pathogenesis of 
various metabolic liver diseases is associated with major deregula-
tions of the insulin signaling pathway, it may be informative to 
determine the liver ploidy profile during the development of these 
types of disorders and consequently whether any ploidy modifica-
tions are involved in the pathophysiology of these diseases.
Methods
Animal experiments. Wistar rats and ob/ob mice (B6.V-Lepob/J; Charles River 
Laboratories) were housed in a temperature-controlled environment with 
12-hour light/12-hour dark cycles and had free access to water and a high-
carbohydrate diet (51.7% of calories from carbohydrate, 5.1% from fat, 
and 21.4% from protein). To modify daily rhythms, cycles were changed 
from 12-hour light/12-hour dark to 18-hour light/6-hour dark or 21-hour 
light/3-hour dark. For diet experiments, rats were randomly assigned to be 
fed the high-carbohydrate diet or the high-fat diet (1.0% of calories from 
carbohydrate, 71.8% from fat, and 28.2% from protein). Before sacrifice, 
the 2 groups were fasted for 24 hours and then refed the same diet for 
18 hours. For STZ treatment, rats received 1 intraperitoneal injection of 
STZ (60 mg/kg in 0.1 M citrate buffer, pH 4.5) on each of days 17, 18, 
and 19 of age. Controls received vehicle. Human insulin (Insulatard; Novo 
Nordisk) was administered by intraperitoneal injection at 5 U/kg body 
mass. For all experiments, animals were sacrificed, and the liver was either 
immediately flash frozen and stored at –80°C or fixed in phosphate-buff-
ered 10% formalin. Blood samples were also collected. Glucose values were 
determined from whole venous blood using an automatic glucose monitor 
(GlucoMen GlycÓ; A. Menarini Diagnostics). Insulin levels in serum were 
measured by ELISA using rat standards according to the manufacturer’s 
guidelines (Mouse/Rat Insulin ELISA; Diagnostics Systems Laboratories 
Inc). Animal studies described herein were reviewed and approved (agree-
ment no. 75-956) by the Directeur départemental des Services Vétérinaires 
of the Prefecture de Police de Paris (Paris, France).
Cell cultures. Hepatocytes were isolated from rat livers by 2-step perfusion 
and were cultured as previously described (21). In these conditions, after 
liver perfusion with collagenase, hepatocytes enter the cell cycle. Mitogen-
ic treatment with EGF allowed these cells to progress synchronously into 
S phase at 48 hours after plating, with maximal mitotic index at 60 hours 
(21). LY294002 (50 μM; Calbiochem), U0126 (30 μM; Calbiochem), iAkt 
inhibitor VIII (1 μM; Calbiochem), and rapamycin (5 nM; Sigma-Aldrich) 
were added 60 hours after plating: 2 hours of treatment for LY294002, 
U0126, and iAkt and 4 hours of treatment for rapamycin.
Real-time PCR analysis. Total RNA (Macherey-Nagel) was isolated from 
rat liver and used as a template for cDNA synthesis (Transcriptor First 
Strand cDNA synthesis; Roche). Quantitative real-time PCR was per-
formed using a LightCycler Instrument (Roche Diagnostics) according 
to the manufacturer’s instructions and with the SYBR green master kit 
(Roche). Primers used were for cyclophilin (sense, 5′-ATGGCACTGGT-
GGCAAGTCC-3′; antisense, 5′-TTGCCATTCCTGGACCCAAA-3′), FAS 
(sense, 5′-ACCTGTCCCAGGTGTGTGAT-3′; antisense, 5′-GCTGTGGAT-
GATGTTGATGA-3′), GK (sense, 5′-CAACATCGTAGGACTTCTCCG-3′; 
antisense, 5′-GGCGGTCTTCATAGTAGCAG-3′), L-PK (sense, 5′-GTT-
GTTTGAGGAGCTACGCC-3′; antisense, 5′-GTCTTCGTCAGCACGAT-
GAT-3′), and SREBP-1c (sense, 5′-TTGAAGACATGCTTCAGCTC-3′; anti-
sense, 5′-GCCTGTGTCTCCTGTCTCA-3′). The values reported for each 
mRNA were corrected to the cyclophilin mRNA values.
Western blot. Total protein extracts were obtained from liver samples and 
primary hepatocyte cultures as previously described (21). Protein extracts 
were resolved by SDS-PAGE, then transferred onto 0.45-μm pore-size nitro-
cellulose membranes. The membranes were incubated overnight at 4°C 
with antibodies against GK (gift from M. Magnusson, Vanderbilt Univer-
sity, Nashville, Tennessee, USA), FAS (gift from I. Dugail, Centre de Recher-
che des Cordeliers, Paris, France), SREBP-1c (NeoMarkers; Interchim Inc.), 
phospho-Akt (Ser473) (BD Biosciences), phospho-p44/42 MAPK (Thr202/
Tyr204) (BD Biosciences), phospho–S6 ribosomal protein (Ser240/244) 
(BD Biosciences), IRβ (C-19; Santa Cruz Biotechnology Inc.), and γ-tubu-
lin (GTU88; Sigma). Horseradish peroxidase–conjugated antibodies (GE 
Healthcare) were used as secondary antibodies. Immunoreactive bands were 
visualized with a chemiluminescence kit (Thermo Fisher Scientific). The 
blots were exposed to KODAK Biomax films, and the IR signal was quanti-
fied using Genesnap version 6.00 and Genetools version 3.07 software (Syn-
gene). In all Western blot experiments, samples were run on the same gel.
Immunohistochemistry. Liver tissue was fixed overnight in formalin, 
embedded in paraffin, and cut into 5-μm-thick slices. Primary hepatocytes 
were fixed in –20°C MetOH for 3 minutes (to stain β-tubulin and 
β-catenin), in 4°C 10% TCA for 15 minutes (to stain RhoA), or in 4°C 4% 
PFA for 15 minutes (to stain F-actin). Immunohistochemistry was per-
formed with mouse anti–β-catenin (diluted 1:200; BD Biosciences), mouse 
anti–β-tubulin (diluted 1:400; Tub 2.1; Sigma-Aldrich), mouse anti-
RhoA (diluted 1:100; Santa Cruz Biotechnology Inc.), and 165 nM Alexa 
Fluor 488 phalloidin (F-actin; Invitrogen). Anti-mouse IgG antibodies 
conjugated with Alexa Fluor 488 or Alexa Fluor 594 (diluted 1:500; 
Invitrogen) were used as secondary antibodies. Hoechst 33342 (0.2 μg/ml; 
Sigma-Aldrich) was included in the final wash to counterstain nuclei. For 
Ki67 labeling, a monoclonal antibody against Ki67 proliferation antigen 
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(diluted 1:400; clone KiS5; DAKO) was used. Goat anti-mouse conjugated 
to horseradish peroxide–labeled polymer (EnVision; DAKO) was used as 
a secondary antibody. Slides were developed with 3-3′-diaminobenzidine 
chromogen and counterstained with Gill hematoxylin.
Image acquisition and analysis. Images were taken using a Nikon Statif 
Eclipse E600 microscope with ×40 magnification, 1.4–0.7 NA PL-APO 
objectives, a DXM1200 cooled CCD camera (Nikon), and ACT-1 (version 
2.63; Universal Imaging). For diploid and tetraploid hepatocyte counting 
experiments, at least 10 randomly chosen fields of liver tissue were imaged 
(more than 2,500 cells analyzed). For each field, 2 different focal planes 
of Hoechst staining were acquired to visualize binucleated tetraploid 
hepatocytes correctly. For β-tubulin staining on liver sections and F-actin/
RhoA staining on fixed cells, z axis stacks were collected using a piezoelec-
tric device mounted at the base of a ×63-magnification, 1.4 NA PL-APO 
objective on a Zeiss DMRA2 microscope with a Coolsnap HQ camera con-
trolled by Metamorph software (version 7.1; Universal Imaging). A total of 
20–30 planes (0.2-μm-thick slices) was captured for each cell and compiled 
as single 2-dimensional projections using ImageJ software (http://rsbweb.
nih.gov/ij/). All images were imported into Photoshop (version CS; Adobe) 
for contrast manipulation and figure assembly.
Statistics. All experiments were performed at least 3 times. Results 
are expressed as mean ± SEM. Mann-Whitney and Student’s 2-sample 
t tests were used for statistical analyses. A P value less than 0.05 was 
considered significant.
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